The global oxygen conservation devices market size is expected to reach USD 3.95 billion by 2030, registering a CAGR of 12.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing prevalence of respiratory diseases is expected to boost the adoption of oxygen conservation devices. According to the Global Asthma Network, nearly 334 million people are affected by asthma worldwide. This shows the potential demand for these devices in the coming years.
According to the WHO, rise in the incidence of COPD and other respiratory disorders is anticipated to boost the demand for oxygen therapy and consequentially increase the adoption of these products. Furthermore, factors such as increasing indoor & outdoor pollution and changing lifestyle contribute to the rising incidence of asthma, thereby fueling demand over the forecast period.
Growing demand for technologically advanced products with potential benefits such as less O2 wastage, ease of use, increased portability, and enhanced patient response are among factors expected to generate lucrative growth opportunities. In addition, well-developed reimbursement structure and supportive regulatory framework are propelling the market. For instance, Medicare policies in the U.S. offer reimbursement for oxygen therapy equipment when it is prescribed by a healthcare professional.
Request a free sample copy or view report summary: Oxygen Conservation Devices Market Report
Reservoir oxygen delivery devices accounted for a leading market share of 33.6% in 2023. The growth depends on their early introduction and high adoption rate among patients and hospitals.
Electromechanical pulsing devices are expected to register the fastest CAGR of 12.2% over the forecast period. Due to their technological feasibility, these devices enhance patient mobility and preserve O2 flow.
The home care segment dominated the market with a share of 41.7% in 2023. The increasing preference for home health care drives patient comfort, the need to reduce hospital-related costs, and the fear of infection accelerates the trend.
The long-term care unit segment is projected to grow at the fastest CAGR of 12.2 % over the forecast period. The global demographic shift towards advanced life-saving devices drives the demand for long-term care facilities.
North America dominated the global market and accounted for the largest revenue share, 34.5%, in 2023. The availability of well-developed primary, secondary, and tertiary hospitals supports market growth in the region.
Asia Pacific oxygen conservation devices market is anticipated to witness significant growth due to the significantly increasing investments in healthcare expenditures.
Major players are involved in various strategies such as mergers & acquisitions to sustain their market position. For instance, in September 2017, Air Liquide acquired Sogo Sangyo Kabushiki Kaisha, thereby increasing its home healthcare and medical gases business in Japan
Grand View Research has segmented the oxygen conservation devices market on the basis of on product, end-use, and region:
Oxygen Conservation Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Reservoir Oxygen Delivery Devices
Electromechanical Pulsing Devices
Transtracheal Catheters
Others
Oxygen Conservation Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Clinics
Long-term Care Units
Home Care
Oxygen Conservation Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
Japan
India
South Korea
Australia
Latin America
Brazil
Middle East and Africa (MEA)
South Africa
List of Key Players in the Oxygen Conservation Devices Market
Invacare Corporation
Philips Respironics
Chart Industries
GF Health Products, Inc.
Drive DeVilbiss Healthcare
Inogen, Inc.
Precision Medical, Inc
CAIRE Inc. (Chart Industries)
Teleflex Incorporated
"The quality of research they have done for us has been excellent..."